Form D · Pharmaceuticals
Incannex Healthcare Inc.
Norwest Nsw, C3 · CIK 0001873875
Offering snapshot reported Mar 17, 2025 · SEC filing
- Reported sold
- $12.5M Offering amount: $12.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2025 | Initial | $12,499,825 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $872K
- Form D file number
- 021-541031
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| R.F. LAFFERTY & CO., INC. | 2498 |
Source: Form D, filed Mar 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Anastassov | Director |
| Luigi M. Barbato | Executive |
| Lekhram Changoer | Executive |
| Robert Clark | Director |
| Joel Latham | Director, Executive |
| Joseph Swan | Executive |
| Troy Valentine | Director |
| Peter Widdows | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8 Century Circuit Ste 105
Norwest Nsw, C3, 2153
Phone: 61 409 840 786
Norwest Nsw, C3, 2153
Phone: 61 409 840 786